Find clinical trials for Lymphoma in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Montréal, QC, CAN:
patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma to determine if ARV-393 may be a possible treatment option.ARV-3...
Phase 1
Montreal, Quebec, Canada and 13 other locations
pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma...
Phase 1
Montréal, Quebec, Canada and 12 other locations
TrAVeRse is a multicentre, open-label, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess the rate of...
Phase 2
Montreal, Quebec, Canada and 28 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Montreal, Quebec, Canada and 215 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Montréal, Quebec, Canada and 94 other locations
The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length...
Phase 3
Montreal, Quebec, Canada and 34 other locations
This is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the AZD0486...
Phase 3
Montreal, Quebec, Canada and 38 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Montréal, Canada and 143 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Montreal, Quebec, Canada and 55 other locations
This is a phase I dose-escalation study of oral PCLX-001, conducted in a multicenter, non-randomized, open-label, non-controlled design. The study is...
Phase 1
Montréal, Quebec, Canada and 3 other locations
Clinical trials
Research sites
Resources
Legal